Practice a tool compares drug interactions with the four marketed DOACs, focusing on interactions commonly encountered in thrombosis/cardiology-based practices
'Her fever was really high. Her heart rate was over 140. She was in agony,' the girl's mother recounted the nightmare that started in an Edmonton walk-in and took them through the clogged emergency departments of two hospitals.
Horizon Pharma will be forced to lower the price on its life-saving Procysbi medication, after the Patented Medicines Prices Review Board (PMPRB) decided the $300,000-a-year drug was too expensive.
The Nova Scotia College of Pharmacists notes that outpatient medications dispensed by hospital pharmacies are now entered into the Nova Scotia Drug Information System (NS DIS).
